A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DOPA

Search Conditions:
Search Keyword : DOPA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: DOPA
Appearance Frequency: 1212 time(s)
Long forms: 46

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
3,4-dihydroxyphenylalanine
(1059 times)
Biochemistry
(191 times)
DA (173 times)
DOPAC (108 times)
TH (61 times)
1948 A new synthesis of 3,4-dihydroxyphenylalanine (dopa).
dopamine
(38 times)
Biomedical Engineering
(5 times)
5-HT (4 times)
TYR (4 times)
EPI (3 times)
1978 Effects of dopamine on haemodynamics and myocardial energetics in man: comparison with effects of isoprenaline and L-noradrenaline.
dioleoylphosphatidic acid
(31 times)
Biochemistry
(17 times)
DOPC (7 times)
AChR (3 times)
DOPS (3 times)
1983 Polymorphic phase preferences of phosphatidic acid: A 31P and 2H NMR study.
1,2-dioleoyl-sn-glycero-3-phosphate
(12 times)
Chemistry
(5 times)
DOPC (2 times)
DOPE (2 times)
AO (1 time)
2003 Low chemical specificity of the nicotinic acetylcholine receptor sterol activation site.
determination of 3,4-dihydroxyphenylalanine
(7 times)
Pharmacology
(2 times)
CA (1 time)
DHPG (1 time)
DOPAC (1 time)
1972 A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.
di-n-octylphosphinic acid
(5 times)
Nanotechnology
(2 times)
TOPO (3 times)
DOPO (2 times)
QDs (2 times)
2008 The trouble with TOPO; identification of adventitious impurities beneficial to the growth of cadmium selenide quantum dots, rods, and wires.
dihydroxyphenylacetic acid
(5 times)
Neurology
(1 time)
HVA (2 times)
AD (1 time)
CNS (1 time)
1978 Dopaminergic mediation of beta-endorphin-induced catalepsy.
dopamine and dihydroxyphenylalanine
(5 times)
Neurology
(2 times)
hTyrH (1 time)
NMPTP (1 time)
PKA (1 time)
1976 Catecholamine metabolism in neuroblastoma.
dopamine and its precursor, 3,4-dihydroxyphenylalanine
(4 times)
Neurology
(2 times)
DOPAC (1 time)
HVA (1 time)
PKA (1 time)
1998 Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis.
10  DA precursor l-3,4-dihydroxyphenylalanine
(3 times)
Vascular Diseases
(2 times)
DA (3 times)
BP (2 times)
ERPF (2 times)
1994 Modulation of natriuresis and renal dopamine excretion by sympathetic activity and the renin-angiotensin-aldosterone system.
11  dual-crystal optical parametric amplification
(3 times)
Biophysics
(3 times)
AlN (1 time)
BBO (1 time)
CEP (1 time)
2013 Compact dual-crystal optical parametric amplification for broadband IR pulse generation using a collinear geometry.
12  dihydroxyphenylalanine-2-14C
(2 times)
Pharmacology
(2 times)
--- 1956 The conversion of dihydroxyphenylalanine-2-C14 (DOPA) to norepinephrine by bovine adrenal medullary homogenates.
13  dioleoyl-PA
(2 times)
Biochemistry
(1 time)
DLPA (1 time)
DSPA (1 time)
LOPA (1 time)
1991 The mitogenic activities of phosphatidate are acyl-chain-length dependent and calcium independent in C3H/10T1/2 cells.
14  diphenolase
(2 times)
Complementary Therapies
(2 times)
FRAP (2 times)
RSA (2 times)
TFC (2 times)
2012 Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract.
15  ductal origin of a pulmonary artery
(2 times)
Cardiology
(2 times)
BT (1 time)
DS (1 time)
PA (1 time)
2014 Pulmonary artery resuscitation for isolated ductal origin ofapulmonary artery.
16  l-dopa
(2 times)
Vascular Diseases
(1 time)
Ccr (1 time)
DA (1 time)
EHT (1 time)
1989 Attenuated renal production of dopamine in patients with low renin essential hypertension.
17  3,4-dihydroxyphenyl-L-ALANIN
(1 time)
Chemistry
(1 time)
--- 2012 Adsorption of Mefp-1: influence of pH on adsorption kinetics and adsorbed amount.
18  6-(F-18)fluoro-L-dihydroxyphenylalanine
(1 time)
Endocrinology
(1 time)
CT (1 time)
FDA (1 time)
FI (1 time)
2015 The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.
19  alpha-methyl-dioxyphenylalanine
(1 time)
Vascular Diseases
(1 time)
--- 1997 Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
20  DA, its precursor levodopamine
(1 time)
Ophthalmology
(1 time)
DA (1 time)
DAergic (1 time)
DOPAC (1 time)
2013 The rat with oxygen-induced retinopathy is myopic with low retinal dopamine.
21  Database Optimized Protein Alignment
(1 time)
Biomedical Research
(1 time)
GCUPS (1 time)
GPUs (1 time)
SW (1 time)
2011 DOPA: GPU-based protein alignment using database and memory access optimizations.
22  decrease of extraneuronal 3.4-dihydroxyphenylacetic acid
(1 time)
Neurology
(1 time)
--- 1994 Intranigral injected iron progressively reduces striatal dopamine metabolism.
23  Decrease of the 3,4-dihydroxyphenylalanine
(1 time)
Science
(1 time)
--- 1971 Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.
24  delivery of 3,4-dihydroxyphenylalanine
(1 time)
Molecular Biology
(1 time)
AAV (1 time)
DA (1 time)
GCH1 (1 time)
2012 Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.
25  density of the membrane by usingdioleoylphosphatidic acid
(1 time)
Biophysics
(1 time)
MO (1 time)
2002 Effect of electrostatic interactions on phase stability of cubic phases of biomembranes.
26  detection of protein-bound 3,4-dihydroxyphenylalanine
(1 time)
Biochemistry
(1 time)
Tyr (1 time)
2001 A highly sensitive method for the determination of protein bound 3,4-dihydroxyphenylalanine as a marker for post-translational protein hydroxylation in human tissues ex vivo.
27  dioctanoyl-5'-phosphatidyladenosine
(1 time)
Biochemistry
(1 time)
DDPA (1 time)
DLPA (1 time)
DMPA (1 time)
1992 Spontaneous formation of helical structures from phospholipid-nucleoside conjugates.
28  dissipative optical parametric amplifiers
(1 time)
Ophthalmology
(1 time)
--- 2015 Optical parametric amplification via non-Hermitian phase matching.
29  Distal origination of the proximal anastomosis
(1 time)
General Surgery
(1 time)
--- 1995 Is infrapopliteal bypass compromised by distal origin of the proximal anastomosis?
30  DOPA accumulation following 3,4-dihydroxyphenylalanine
(1 time)
Chemistry
(1 time)
3-MT (1 time)
DOPAC (1 time)
HVA (1 time)
1987 Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury.
31  DOPA plus dopamine
(1 time)
Chemistry, Clinical
(1 time)
--- 1978 Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine).
32  DOPA using the in vivo gamma-butyrolactone procedure
(1 time)
Drug Therapy
(1 time)
DA (1 time)
FI (1 time)
SG (1 time)
1984 Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
33  DOPAC and 3,4-dihydroxyphenylalanine
(1 time)
Neurology
(1 time)
DA (1 time)
DOPAC (1 time)
1989 A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.
34  DOPAC, dihydroxyphenylalanine
(1 time)
Medicine
(1 time)
DA (1 time)
DHPG (1 time)
DOPAC (1 time)
1995 Decreased stress responsivity of central and peripheral catecholaminergic systems in aged 344/N Fischer rats.
35  dopamine agonists--bromocriptine, amantadine 3,4-dihydroxyphenylalanine
(1 time)
Psychopharmacology
(1 time)
NMS (1 time)
1991 Drug treatment of the neuroleptic malignant syndrome.
36  dopamine receptor binding, 3,4-dihydroxyphenylalanine
(1 time)
Chemistry
(1 time)
DA (1 time)
DOPAC (1 time)
HVA (1 time)
1987 Effects of perinatal vitamin B6 deficiency on dopaminergic neurochemistry.
37  dopamine, noradrenaline and L-dihydroxyphenylalanine
(1 time)
Anatomy
(1 time)
--- 1990 Evidence for the existence of L-dopa- and dopamine-immunoreactive nerve cell bodies in the caudal part of the dorsal motor nucleus of the vagus nerve.
38  dopaminergic activity, 3,4-dihydroxyphenylalanine
(1 time)
Dentistry
(1 time)
DA (1 time)
DOPAC (1 time)
NFMA (1 time)
1999 A possible attenuation of stress-induced increases in striatal dopamine metabolism by the expression of non-functional masticatory activity in the rat.
39  dose of carbidopa/levodopa
(1 time)
Brain
(1 time)
AMPH (1 time)
MEPH (1 time)
MEPs (1 time)
2017 Effects of monoaminergic drugs on training-induced motor cortex plasticity in older adults.
40  dose of dihydroxyphenylalanine
(1 time)
Vascular Diseases
(1 time)
--- 1994 Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
41  dose of L-1-3-4-dihydroxyphenylalanine
(1 time)
Neurology
(1 time)
AD (1 time)
DOPS (1 time)
FST (1 time)
2016 Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.
42  fluorine-18-desoxyphenylalanine
(1 time)
Nuclear Medicine
(1 time)
--- 2015 Current status of 18F-DOPA PET imaging in the detection of brain tumor recurrence.
43  iron(III)-3,4-dihydroxyphenylalanine
(1 time)
Chemistry
(1 time)
NP (1 time)
2015 Mussel-Inspired Protein Nanoparticles Containing Iron(III)-DOPA Complexes for pH-Responsive Drug Delivery.
44  L-(11C)-3'4-Dihydrophenylalanine
(1 time)
Dementia
(1 time)
FDG (1 time)
PET (1 time)
2015 PET and the multitracer concept in the study of neurodegenerative diseases.
45  L-3,4-Dihydroxyphenyl(3-(14)C)Ala
(1 time)
Physiology
(1 time)
--- 2000 Cloning and expression of cytochrome P450 enzymes catalyzing the conversion of tyrosine to p-hydroxyphenylacetaldoxime in the biosynthesis of cyanogenic glucosides in Triglochin maritima.
46  nucleus--3,4-dihydroxyphenylalanine
(1 time)
Chemistry
(1 time)
alpha-met-NA (1 time)
DA (1 time)
DOPAC (1 time)
1982 On the mechanism of the involvement of monoamine oxidase in catecholamine-stimulated prostaglandin biosynthesis in particulate fraction of rat brain homogenates: role of hydrogen peroxide.